May 2023
-
05.31.2023 Diseases & Conditions Lyme Disease Research U.S. Travel Update: Lyme Disease in Europe -
05.26.2023 Events Cancer Diseases & Conditions Research Pfizer to Share Oncology Advancements at ASCO Annual Meeting -
05.11.2023 Covid-19 Diseases & Conditions Health Equity Vaccines Global and U.S. Agencies Declare End of COVID-19 Emergency
February 2023
-
02.03.2023 Events Cancer Diseases & Conditions Health Equity Patient Centricity Wellness Closing the Cancer Care Gap: World Cancer Day and Beyond
September 2021
-
09.16.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
May 2021
-
05.19.2021 Events Breast Cancer Cancer Diseases & Conditions Making a Global Impact in Breast Cancer Care -
05.07.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines An Open Letter from Pfizer Chairman and CEO to Colleagues
March 2021
-
03.09.2021 Perspectives Albert Bourla Business Clinical Trials Covid-19 Diseases & Conditions Leadership mRNA Partnerships Patient Centricity Technology Vaccines Wellness Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
January 2021
-
01.29.2021 Events Cancer Diseases & Conditions Some older people living with cancer aim for remission but lack needed resources to help make treatment decisions, global survey reveals -
01.22.2021 Perspectives Albert Bourla Business Covid-19 Diseases & Conditions mRNA Partnerships Patient Centricity Responsibility Vaccines Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
December 2020
-
12.15.2020 Perspectives Albert Bourla Covid-19 COVID-19 Vaccine Efforts Diseases & Conditions Vaccines Distributing Our COVID-19 Vaccine to the World
October 2020
-
10.15.2020 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines An Open Letter from Pfizer Chairman and CEO Albert Bourla